Expression of α6 integrin subunit is associated with malignancy in gastric gastrointestinal stromal tumors

Medical Science Monitor

Volumn 13, Issue 2, 2007, Pages

  Takeyama, Hiromitsu ^a   Funahashi, Hitoshi ^a   Sawai, Hirozumi ^a   Takahashi, Hiroki ^a   Yamamoto, Minoru ^a   Akamo, Yoshimi ^a   Manabe, Tadao ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Gastrointestinal stromal tumor; Integrin; p53 protein; Tumor malignancy

Indexed keywords

ALPHA6 INTEGRIN; CYCLINE; PROTEIN P53; STEM CELL FACTOR RECEPTOR; VERY LATE ACTIVATION ANTIGEN 5; TP53 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MEDICAL RECORD; MITOSIS RATE; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL; TUMOR VOLUME; ADULT; AGED; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA6; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33846902412     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Miettinen M: Gastrointestinal stromal tumors. An immunohistochemical study of cellular differentiation. Am J Clin Pathol, 1988; 89: 601-10
2. Ueyama T, Guo K, Hashimoto H et al: A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer, 1992; 69: 947-55
3. Franquemont DW, Frierson HF: Muscle differentiation and clinicopathological features of gastrointestinal stromal tumors. Am J Surg Pathol, 1992; 16: 947-54
4. th ed. Mosby Year Book, St. Louis, 645-470
5. Monihan JM, Carr NJ, Sobin LH: CD34 immunoexpression in stromal tumors of the gastrointestinal tract and in mesenteric fibromatoses. Histopathology, 1994; 25: 469-73
6. van de Rijn M, Hendrickson MR, Rouse RV: CD34 expression by gastrointestinal tract stromal tumors. Hum Pathol, 1994; 25: 766-71
7. Miettinen M, Violainen M, Rikala MS: Gastrointestinal stromal tumors: Value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol, 1995; 19: 207-16
8. Hirota S, Isozaki K, Moriyama Y et al: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science, 1998; 279: 577-80
9. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM: Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol, 1998; 152: 1259-69
10. Antonescu CR, Viale A, Sarran L et al: Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Clin Cancer Res, 2004; 10: 3282-90
11. Rossi G, Sartori G, Valli R et al: The value of c-kit mutational analysis in a cytokeratin positive gastrointestinal stromal tumour. J Clin Pathol, 2005; 58: 991-93
12. Isozaki K, Hirota S, Nakama A et al: Disturbed intestinal movement, bile reflux to the stomach, and deficiency of c-kit-expressing cells in Ws/Ws mutant rats. Gastroenterology, 1995; 109: 456-64
13. Torihashi S, Ward SM, Nishikawa S et al: c-kit-dependent development of interstitial cells and electrical activity in the murine gastrointestinal tract. Cell Tissue Res, 1995; 280: 97-111
14. Ogasawara N, Tsukamoto T, Inada K et al.: Frequent c-Kit gene mutations not only in gastrointestinal stromal tumors but also in interstitial cells of Cajal in surrounding normal mucosa. Cancer Lett, 2005; 230: 199-210
15. Rumessen JJ, Mikkelsen HB, Thuneberg L: Ultrastructure of interstitial cells of Cajal associated with deep muscular plexus of human small intestine. Gastroenterology, 1992; 102: 56-68
16. Tazawa K, Tsukada K, Makuuchi H, Tsutsumi Y: An immunohistochemical and clinicopathological study of gastrointestinal stromal tumors. Pathol Int, 1999; 49: 786-92
17. Miettinen M, Sarlomo-Rikala M, Lasota J: Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol, 1999; 30: 1213-20
18. Seidal T, Edvardsson H: Expression of c-kit (CD117) and Ki67 provide information about the possible cell of origin and clinical course of gastrointestinal stromal tumors. Histopathology, 1999; 34: 416-24
19. Emory TS, Sobin LH, Lukes L et al: Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol, 1999; 23: 82-87
20. Kovac D, Petrovecki M, Jasic M et al: Prognostic factors of gastrointestinal stromal tumors. Anticancer Res, 2002; 22: 1913-17
21. Schwartz MA, Assoian RK: Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci, 2001; 114: 2553-60
22. Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell, 2002; 110: 673-87
23. Sawai H, Okada Y, Funahashi H et al: Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation. Mol Cancer, 2005; 4: 37
24. 1-integrin and urokinase plasminogen activator receptor expression. BMC Cell Biol, 2006; 7: 8
25. Amin MB, Ma CK, Linden MD et al: Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors, correlation with mitotic count and clinical outcome. Am J Clin Pathol, 1993; 100: 428-32
26. Fletcher CDM, Berman JJ, Corless C et al: Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol, 2002; 10: 81-89
27. Miettinen M, El-Rifai W, Sobin LH, Lasota J: Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol, 2002; 33: 478-83
28. Kosmadakis N, Visvardis EE, Kartsaklis P et al: The role of surgery in the management of gastrointestinal stromal tumors (GISTs) in the era of imatinib mesylate effectiveness. Surg Oncol, 2005; 14: 75-84
29. Blackstein ME, Blay JY, Corless C st al: Gastrointestinal stromal tumors: consensus statement on diagnosis and treatment. Can J Gastroenterol, 2006; 20: 157-63
30. Chang MS, Choe G, Kim WH, Kim YI: Small intestinal stromal tumors: a clinicopathologic study of 31 tumors. Pathol Int, 1998; 48: 341-47
31. Aparicio T, Boige V, Sabourin JC et al: Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours. Eur J Surg Oncol, 2004; 30: 1098-103
32. Boni L, Benevento A, Dionigi G et al: Surgical resection for gastrointestinal stromal tumors (GIST): experience on 25 patients. World J Surg Oncol, 2005; 3: 78
33. Iwahashi M, Takifuji K, Ojima T et al: Surgical management of small gastrointestinal stromal tumors of the stomach. World J Surg, 2006; 30: 28-35
34. Evans HL: Smooth muscle tumors of the gastrointestinal tract: a study of 56 cases followed for a minimum of 10 years. Cancer, 1985; 56: 2242-50
35. Koga H, Ochiai A, Nakanishi Y et al.: Reevaluation of prognostic factors in gastric leiomyosarcoma. Am J Gastroenterol, 1995; 90: 1307-12
36. Ng EH, Pollock RE, Munsell MF et al: Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg, 1992; 215: 68-77
37. Vander Noot MR III, Eloubeidi MA, Chen VK et al: Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer, 2004; 102: 157-63
38. Springer TA, Lasky LA: Sticky sugars for selectins. Nature, 1991, 349: 196-97
39. Kuijpers TW, Hakkert BC, Hart MH, Roos D: Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. J Cell Biol, 1992; 117: 565-72
40. Surazynski A, Palka J, Wolczynski S: Acetylsalicylic acid-dependent inhibition of collagen biosynthesis and beta1-integrin signaling in cultured fibroblasts. Med Sci Monit, 2004; 10(6): BR175-79
41. Engl T, Makarević J, Relja B et al: Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy. BMC Cancer, 2005; 5: 4
42. Shirk AJ, Kuver R: Epidermal growth factor mediates detachment from and invasion through collagen I and Matrigel in Capan-1 pancreatic cancer cells. BMC Gastroenterology, 2005; 5: 12
43. Sawai H, Okada Y, Funahashi H et al: Anaplastic carcinoma of the pancreas with squamous features: report of a case and immunohistochemical study. Med Sci Monit, 2005; 11(11): CS65-68
44. Funahashi H, Takeyama H, Sawai H et al: Alteration of integrin expression by glial cell line-derived neurotrophic factor (GDNF) in human pancreatic cancer cells. Pancreas, 2003; 27: 190-96
45. Sawai H, Funahashi H, Yamamoto M et al: Interleukin-1alpha enhances integrin alpha(6)beta(1) expression and metastatic capability of human pancreatic cancer. Oncology, 2003; 65: 167-73
46. Nishida T, Hiroda S, Taniguchi M et al: Familial gastrointestinal stromal tumors with germline mutation of the KIT gene. Nat Genet, 1998; 19: 323-24
47. Heinrich MC, Rubin BP, Longley BJ, Fletcher JA: Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol, 2002; 33: 484-95